4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3, 4-d]pyrimidine (PP2) induces apoptosis and decreases the expression of PRDX3 in human breast cancer MCF-7 cells [22]. Here, PRDX3 is linked to breast cancer.